• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨密度与绝经后乳腺癌风险。

Bone mineral density and risk of postmenopausal breast cancer.

机构信息

CancerCare Manitoba, 675 McDermot, Avenue, Winnipeg, MB R3E 0V9, Canada.

出版信息

Breast Cancer Res Treat. 2011 Apr;126(3):679-86. doi: 10.1007/s10549-010-1138-y. Epub 2010 Sep 14.

DOI:10.1007/s10549-010-1138-y
PMID:20838879
Abstract

To determine if higher bone mineral density (BMD) is a risk factor for breast cancer in women age 50 years and older. 37,860 women ≥ 50-year old with no previous breast cancer diagnosis had baseline BMD assessment between January 1999 and December 2007. Cox proportional hazards models were created for time to a new breast cancer as a function of lumbar spine or femoral neck BMD quartile (1st = lowest as reference) with adjustment for relevant covariates. A secondary analysis was performed to look for an association with estrogen receptor-positive (ER-positive) breast cancers. 794 invasive and in situ breast cancers (484 ER-positive) occurred with a median follow up of 5.4 years. Increased breast cancer risk was seen for the 3rd and 4th quartiles of lumbar spine BMD with hazard ratios (HRs) of 1.26 (95% CI, 1.01-1.58) and 1.45 (95% CI, 1.16-1.81), respectively and for the 3rd quartile of femoral neck BMD with a HR of 1.33 (95% CI, 1.07-1.64). A test for linear trend showed that lumbar spine BMD (P < 0.001) and femoral neck BMD (P = 0.04) were associated with increased risk. Higher lumbar spine BMD was also associated with increased risk of ER-positive breast cancer with HR of 1.45 (95% CI, 1.08-1.94), and 1.68 (95% CI, 1.24-2.27) for women in the 2nd and 4th quartiles, respectively. A test for linear trend showed lumbar spine BMD was associated with increasing risk of ER-positive breast cancer (P = 0.003). Increased ER-positive breast cancer risk was seen for the 3rd quartile of femoral neck BMD with a HR of 1.43 (95% CI, 1.08-1.89). Higher lumbar spine and femoral neck BMD are associated with higher risk of breast cancer in women ≥50-year old. Lumbar spine and femoral neck BMD are associated with increased risk of ER-positive breast cancer.

摘要

为了确定骨密度(BMD)较高是否是 50 岁及以上女性乳腺癌的危险因素。1999 年 1 月至 2007 年 12 月期间,对 37860 名无乳腺癌既往病史的 50 岁以上女性进行了基线 BMD 评估。建立了新乳腺癌发病时间的 Cox 比例风险模型,作为腰椎或股骨颈 BMD 四分位(第 1 四分位为最低参考)的函数,调整了相关协变量。进行了二次分析以寻找与雌激素受体阳性(ER 阳性)乳腺癌的关联。中位随访 5.4 年后,发生 794 例浸润性和原位乳腺癌(484 例 ER 阳性)。腰椎 BMD 的第 3 四分位和第 4 四分位的乳腺癌风险增加,风险比(HR)分别为 1.26(95%CI,1.01-1.58)和 1.45(95%CI,1.16-1.81),而股骨颈 BMD 的第 3 四分位 HR 为 1.33(95%CI,1.07-1.64)。线性趋势检验显示,腰椎 BMD(P<0.001)和股骨颈 BMD(P=0.04)与风险增加相关。腰椎 BMD 较高也与 ER 阳性乳腺癌风险增加相关,第 2 四分位和第 4 四分位的 HR 分别为 1.45(95%CI,1.08-1.94)和 1.68(95%CI,1.24-2.27)。线性趋势检验显示,腰椎 BMD 与 ER 阳性乳腺癌风险增加相关(P=0.003)。股骨颈 BMD 的第 3 四分位 HR 为 1.43(95%CI,1.08-1.89),与 ER 阳性乳腺癌风险增加相关。50 岁及以上女性腰椎和股骨颈 BMD 较高与乳腺癌风险增加相关。腰椎和股骨颈 BMD 与 ER 阳性乳腺癌的风险增加相关。

相似文献

1
Bone mineral density and risk of postmenopausal breast cancer.骨密度与绝经后乳腺癌风险。
Breast Cancer Res Treat. 2011 Apr;126(3):679-86. doi: 10.1007/s10549-010-1138-y. Epub 2010 Sep 14.
2
Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.雷洛昔芬治疗8年后对骨骼的影响:来自与Evista(依维斯他)相关的持续结果(CORE)研究的结果
J Bone Miner Res. 2005 Sep;20(9):1514-24. doi: 10.1359/JBMR.050509. Epub 2005 May 16.
3
Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.低骨量或骨质疏松绝经后妇女的骨量、浸润性乳腺癌发病率与雷洛昔芬治疗之间的关系
Curr Med Res Opin. 2008 Mar;24(3):807-13. doi: 10.1185/030079908X273282. Epub 2008 Feb 5.
4
Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factors.老年女性乳腺癌的危险因素:骨密度及其他既定危险因素的相对贡献
Breast Cancer Res Treat. 2007 Apr;102(2):181-8. doi: 10.1007/s10549-006-9326-5. Epub 2006 Sep 21.
5
A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.一项关于类风湿关节炎骨密度的多中心横断面研究。意大利类风湿关节炎骨量研究组。
J Rheumatol. 2000 Nov;27(11):2582-9.
6
Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifene.他莫昔芬或托瑞米芬使用3年期间及之后的骨矿物质密度变化。
Maturitas. 2004 Jul 15;48(3):321-7. doi: 10.1016/j.maturitas.2004.02.018.
7
The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer.氯膦酸盐和抗雌激素对绝经后乳腺癌妇女雌激素撤退相关骨质流失的影响。
Br J Cancer. 2001 Apr 20;84(8):1047-51. doi: 10.1054/bjoc.2001.1729.
8
Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy.芬兰女性绝经后早期骨质流失与雌激素受体基因PvuII多态性相关:激素替代疗法的影响
J Bone Miner Res. 2000 Feb;15(2):315-21. doi: 10.1359/jbmr.2000.15.2.315.
9
Validation of the OSTA index for discriminating between high and low probability of femoral neck and lumbar spine osteoporosis among Thai postmenopausal women.泰国绝经后女性中用于区分股骨颈和腰椎骨质疏松症高概率与低概率的OSTA指数的验证
J Med Assoc Thai. 2004 Nov;87(11):1286-92.
10
Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy.雷洛昔芬治疗下骨矿物质密度与椎体骨折发生风险之间的关系。
J Bone Miner Res. 2002 Jan;17(1):1-10. doi: 10.1359/jbmr.2002.17.1.1.

引用本文的文献

1
A causal relationship between bone mineral density and breast cancer risk: a mendelian randomization study based on east Asian population.骨密度与乳腺癌风险之间的因果关系:基于东亚人群的孟德尔随机化研究。
BMC Cancer. 2024 Sep 14;24(1):1148. doi: 10.1186/s12885-024-12908-0.
2
Bone mineral density in women newly diagnosed with breast cancer: a prospective cohort study.新诊断乳腺癌女性的骨矿物质密度:一项前瞻性队列研究。
NPJ Breast Cancer. 2022 Feb 17;8(1):21. doi: 10.1038/s41523-022-00388-z.
3
Analyses of the association between breast cancer and osteoporosis/fracture history: a cross-sectional study using KoGES HEXA data.
乳腺癌与骨质疏松/骨折史相关性的分析:基于 KoGES HEXA 数据的横断面研究。
Arch Osteoporos. 2021 Jun 19;16(1):98. doi: 10.1007/s11657-021-00947-0.
4
Evaluation of baseline fracture risk in younger postmenopausal women with breast cancer using different risk assessment methods.评估乳腺癌年轻绝经后女性的基线骨折风险,使用不同的风险评估方法。
Skeletal Radiol. 2020 Jun;49(6):1015-1019. doi: 10.1007/s00256-020-03378-z. Epub 2020 Jan 24.
5
Fracture Risk in Women with Breast Cancer Initiating Aromatase Inhibitor Therapy: A Registry-Based Cohort Study.乳腺癌患者起始芳香化酶抑制剂治疗后的骨折风险:基于注册的队列研究。
Oncologist. 2019 Nov;24(11):1432-1438. doi: 10.1634/theoncologist.2019-0149. Epub 2019 Jul 10.
6
High Bone Mineral Density of the Lumbar Spine Is Positively Associated with Breast Cancer.腰椎骨矿物质密度高与乳腺癌呈正相关。
Biomed Res Int. 2019 May 23;2019:8010356. doi: 10.1155/2019/8010356. eCollection 2019.
7
Relationship between bone mineral density and the risk of breast cancer: a systematic review and dose-response meta-analysis of ten cohort studies.骨密度与乳腺癌风险之间的关系:十项队列研究的系统评价和剂量反应荟萃分析
Cancer Manag Res. 2019 Feb 13;11:1453-1464. doi: 10.2147/CMAR.S188251. eCollection 2019.
8
Bone mineral density and breast cancer risk: Results from the Vorarlberg Health Monitoring & Prevention Program and meta-analysis.骨密度与乳腺癌风险:来自福拉尔贝格健康监测与预防项目的结果及荟萃分析
Bone Rep. 2017 Sep 21;7:83-89. doi: 10.1016/j.bonr.2017.09.004. eCollection 2017 Dec.
9
The Relationship between Bone Mineral Density and Estrogen Receptor Positivity in Patients with Breast Cancer.乳腺癌患者骨密度与雌激素受体阳性之间的关系
J Breast Health. 2016 Jul 1;12(3):119-122. doi: 10.5152/tjbh.2016.2961. eCollection 2016 Jul.
10
Bone mineral density and mammographic density in Mexican women.墨西哥女性的骨矿物质密度和乳腺X线密度。
Cancer Causes Control. 2016 Jan;27(1):39-46. doi: 10.1007/s10552-015-0680-7.